Top Story

Windward Bio launches to develop potential best-in-class antibody against asthma and COPD

Windward Bio launches to develop potential best-in-class antibody against asthma and COPD

14-Jan-2025

|

By Larissa Warneck-Silvestrin

Editor's Choice

FDA approves first mesenchymal stromal cell therapy

FDA approves first mesenchymal stromal cell therapy

19-Dec-2024

|

By Clara Rodriguez Fernandez

Headlines

Alchemab and Lilly collaborate to discover and develop ALS therapies

MaaT Pharma’s microbiome therapy scores phase 3 win

Adcentrx launches Phase 1 study for its next-generation ADC...

BrainChild Bio advances development of CAR T therapy for pediatric...

Orbis Medicines bags €90 million Series A to develop oral...

Teva and Sanofi’s IBD drug hits Phase 2 targets

→

In focus

Aditum Bio and Leads Biolabs join forces in new company to fight autoimmune diseases

07-Nov-2024 By Larissa Warneck-Silvestrin

Notes on compliance: Don’t just get compliant, stay compliant – Five practical ways to get USP 1116 done

Paid for and content provided by Thermo Fisher Scientific

Abzena announces major expansion of its biologics manufacturing facility

31-Oct-2024 By Larissa Warneck-Silvestrin

An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market

Paid for and content provided by Scorpius BioManufacturing

Featured

Insight

Top 10 rare disease pharma sees 10.4% rise in therapy start

By Liza Laws

Top 10 rare disease pharma sees 10.4% rise in therapy start

Bio developments

→

Windward Bio launches to develop potential best-in-class antibody against asthma and COPD

Windward Bio launches to develop potential best-in-class antibody against asthma and COPD

14-Jan-2025

By Larissa Warneck-Silvestrin

MaaT Pharma’s microbiome therapy scores phase 3 win

MaaT Pharma’s microbiome therapy scores phase 3 win

09-Jan-2025

By Helen Albert

Alchemab and Lilly collaborate to discover and develop ALS therapies

Alchemab and Lilly collaborate to discover and develop ALS therapies

09-Jan-2025

By Larissa Warneck-Silvestrin

Partner insightMore →

Internal Standard (IS) Variation Case Studies: Emerging from Three Common IS Challenges

Content provided by WuXi AppTec

ICH M10 Guidance: Harmonization and Modification to Bioanalytical Method Variation

Content provided by WuXi AppTec

Difco TC Yeastolate UF in scale-up optimization

Content provided by Thermo Fisher Scientific Gibco Culture for Bioprocessing

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences

Markets & regulation

→

FDA approves first mesenchymal stromal cell therapy

FDA approves first mesenchymal stromal cell therapy

19-Dec-2024

By Clara Rodriguez Fernandez

Cell and gene therapy access model launches in US

Cell and gene therapy access model launches in US

05-Dec-2024

By Helen Albert

BridgeBio wins FDA approval for inherited cardiomyopathy treatment

BridgeBio wins FDA approval for inherited cardiomyopathy treatment

26-Nov-2024

By Helen Albert

Helen Harrington’s journey: Patience, passion, and problem-solving

Helen Harrington’s journey: Patience, passion, and problem-solving

20-Nov-2024

By Liza Laws

Contract manufacturing & logistics

→

Eli Lilly invests $3bn in injectable drug manufacturing facility

Eli Lilly invests $3bn in injectable drug manufacturing facility

10-Dec-2024

By Clara Rodriguez Fernandez

Adragos Pharma snaps up Baccinex to expand CDMO network

Adragos Pharma snaps up Baccinex to expand CDMO network

26-Nov-2024

Abzena’s advanced drug development showcased at CPHI Milan

Abzena’s advanced drug development showcased at CPHI Milan

01-Nov-2024

By Liza Laws

CRO NovAliX teams with Bruker to advance drug development

CRO NovAliX teams with Bruker to advance drug development

29-Oct-2024

By Liza Laws

Expand your knowledge

Industry Newsletters

Choose from regular, topic-based and special edition briefings

Resource centre

Discover cutting edge insight from our partners

Events & webinars

Explore our programme of live & on-demand content